Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24908746 | 0.72 | MGLL (0.35) | — | |
| SCHEMBL14771847 | 0.67 | MGLL (0.46) | CA2CA1 | |
| SCHEMBL37874 | 0.67 | CA2 (0.56) | CA2CA1PTPN1PTPN11 | |
| SCHEMBL4457449 | 0.67 | CA2 (0.56) | CA2CA1PTPN1PTPN11 | |
| SCHEMBL16441095 | 0.66 | PIK3CD (0.31) | — | |
| SCHEMBL6897756 | 0.64 | CA2 (0.53) | CA2CA1PTPN1PTPN11 | |
| SCHEMBL6275307 | 0.64 | CA2 (0.53) | CA2CA1PTPN1PTPN11 | |
| SCHEMBL9982903 | 0.64 | CA2 (0.53) | CA2CA1PTPN1PTPN11 | |
| SCHEMBL6699884 | 0.64 | CA2 (0.53) | CA2CA1PTPN1PTPN11 | |
| Ammonia Solution, Strong SCHEMBL1583080 | 0.64 | CA2 (0.53) | CA2CA1PTPN1PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018000-B2 | Lithium salts of cyano-substituted imidazole for lithium ion batteries | HYDRO-QUéBEC (CA) | 2024-06-25 | — | — | US | disclosed |
| US-12018000-B2 | Lithium salts of cyano-substituted imidazole for lithium ion batteries | HYDRO-QUéBEC (CA) | 2024-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018000-B2 | Lithium salts of cyano-substituted imidazole for lithium ion batteries | HCN2, HCN3, HLCS | CA2 49/4885CA1 292/4885PTPN1 3158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.